CA215 and GnRH receptor as targets for cancer therapy
- Author
- LEE, Gregory1 ; CHEUNG, Anthony P1 ; JIANG GU3 ; BIXIA GE1 ; MINGANG ZHU1 ; GIOLMA, Brett1 ; BO LI1 ; WONG, Eric1 ; YU LI2 ; YU WANG2 ; ZINAN CHEN2
[1] Andrology Laboratory, University of British Columbia Center for Reproductive Health, 4500 Oak Street, Vancouver, BC V6H 3N1, Canada
[2] Department of Cell Engineering, Fourth Military Medical University, Xi'an, China
[3] Molecular Pathology Laboratory, Shantou University Medical College, Shantou, China - Source
Cancer immunology and immunotherapy. 2012, Vol 61, Num 10, pp 1805-1817, 13 p ; ref : 29 ref
- CODEN
- CIIMDN
- ISSN
- 0340-7004
- Scientific domain
- Biochemistry, molecular biology, biophysics; Medical oncology; Immunology, immunopathology, allergology
- Publisher
- Springer, Heidelberg
- Publication country
- Germany
- Document type
- Article
- Language
- English
- Author keyword
- CA215 Carbohydrate-associated epitope(s) GHR106 GnRH receptor Immunoglobulin superfamily proteins RP215
- Keyword (fr)
- Déterminant antigénique Glucide Gonadotrophine RH Immunoglobuline Immunothérapie Multigène Protéine Récepteur biologique Thérapeutique ciblée Traitement Tumeur maligne Cancer Facteur libération hormonale Hormone hypothalamique
- Keyword (en)
- Antigenic determinant Carbohydrate Gonadotropin RH Immunoglobulins Immunotherapy Multigene family Protein Biological receptor Targeted therapy Treatment Malignant tumor Cancer Hormone releasing factor Hypothalamic hormone
- Keyword (es)
- Determinante antigénico Glúcido Gonadotropina RH Inmunoglobulina Inmunoterapia Multigén Proteína Receptor biológico Terapéutica dirigida Tratamiento Tumor maligno Cáncer Factor liberación hormonal Hormona hipotalámica
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R03 Immunotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 26408488
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/s00262-012-1230-8 
https://dx.doi.org/10.1007/s00262-012-1230-8
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00262-012-1230-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:53:\"CA215 and GnRH receptor as targets for cancer therapy\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Cancer immunology and immunotherapy\";s:9:\"\u0000*\u0000stitle\";s:26:\"Cancer immunol. immunother\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"61\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1805\";s:8:\"\u0000*\u0000epage\";s:4:\"1817\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-7004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LEE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Gregory\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"CHEUNG, Anthony P\";i:1;s:8:\"JIANG GU\";i:2;s:8:\"BIXIA GE\";i:3;s:11:\"MINGANG ZHU\";i:4;s:13:\"GIOLMA, Brett\";i:5;s:5:\"BO LI\";i:6;s:10:\"WONG, Eric\";i:7;s:5:\"YU LI\";i:8;s:7:\"YU WANG\";i:9;s:10:\"ZINAN CHEN\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIIMDN\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:53:\"CA215 and GnRH receptor as targets for cancer therapy\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00262-012-1230-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:53:\"CA215 and GnRH receptor as targets for cancer therapy\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Cancer immunology and immunotherapy\";s:9:\"\u0000*\u0000stitle\";s:26:\"Cancer immunol. immunother\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"61\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1805\";s:8:\"\u0000*\u0000epage\";s:4:\"1817\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-7004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LEE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Gregory\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"CHEUNG, Anthony P\";i:1;s:8:\"JIANG GU\";i:2;s:8:\"BIXIA GE\";i:3;s:11:\"MINGANG ZHU\";i:4;s:13:\"GIOLMA, Brett\";i:5;s:5:\"BO LI\";i:6;s:10:\"WONG, Eric\";i:7;s:5:\"YU LI\";i:8;s:7:\"YU WANG\";i:9;s:10:\"ZINAN CHEN\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIIMDN\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:53:\"CA215 and GnRH receptor as targets for cancer therapy\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00262-012-1230-8\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00262-012-1230-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:53:\"CA215 and GnRH receptor as targets for cancer therapy\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Cancer immunology and immunotherapy\";s:9:\"\u0000*\u0000stitle\";s:26:\"Cancer immunol. immunother\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"61\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1805\";s:8:\"\u0000*\u0000epage\";s:4:\"1817\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-7004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LEE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Gregory\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"CHEUNG, Anthony P\";i:1;s:8:\"JIANG GU\";i:2;s:8:\"BIXIA GE\";i:3;s:11:\"MINGANG ZHU\";i:4;s:13:\"GIOLMA, Brett\";i:5;s:5:\"BO LI\";i:6;s:10:\"WONG, Eric\";i:7;s:5:\"YU LI\";i:8;s:7:\"YU WANG\";i:9;s:10:\"ZINAN CHEN\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIIMDN\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:53:\"CA215 and GnRH receptor as targets for cancer therapy\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00262-012-1230-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:53:\"CA215 and GnRH receptor as targets for cancer therapy\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Cancer immunology and immunotherapy\";s:9:\"\u0000*\u0000stitle\";s:26:\"Cancer immunol. immunother\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"61\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1805\";s:8:\"\u0000*\u0000epage\";s:4:\"1817\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-7004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LEE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Gregory\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"CHEUNG, Anthony P\";i:1;s:8:\"JIANG GU\";i:2;s:8:\"BIXIA GE\";i:3;s:11:\"MINGANG ZHU\";i:4;s:13:\"GIOLMA, Brett\";i:5;s:5:\"BO LI\";i:6;s:10:\"WONG, Eric\";i:7;s:5:\"YU LI\";i:8;s:7:\"YU WANG\";i:9;s:10:\"ZINAN CHEN\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIIMDN\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:53:\"CA215 and GnRH receptor as targets for cancer therapy\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00262-012-1230-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:53:\"CA215 and GnRH receptor as targets for cancer therapy\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Cancer immunology and immunotherapy\";s:9:\"\u0000*\u0000stitle\";s:26:\"Cancer immunol. immunother\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"61\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1805\";s:8:\"\u0000*\u0000epage\";s:4:\"1817\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-7004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LEE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Gregory\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"CHEUNG, Anthony P\";i:1;s:8:\"JIANG GU\";i:2;s:8:\"BIXIA GE\";i:3;s:11:\"MINGANG ZHU\";i:4;s:13:\"GIOLMA, Brett\";i:5;s:5:\"BO LI\";i:6;s:10:\"WONG, Eric\";i:7;s:5:\"YU LI\";i:8;s:7:\"YU WANG\";i:9;s:10:\"ZINAN CHEN\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIIMDN\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:53:\"CA215 and GnRH receptor as targets for cancer therapy\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
